期刊文献+

雷珠单抗联合光动力疗法对湿性年龄相关性黄斑变性患者视觉功能、敏感度及血清VEGF含量的影响 被引量:15

Effect of Lucentis combined with photodynamic therapy on visual performance and sensitivity as well as serum VEGF levels in patients with wet age-related macular degeneration
下载PDF
导出
摘要 目的:分析雷珠单抗联合光动力疗法对湿性年龄相关性黄斑变性患者视觉功能、敏感度及血清VEGF含量的影响。方法:将在本院接受治疗的湿性年龄相关性黄斑变性患者78例(78眼)纳入研究,所有患者根据治疗方式不同随机分为观察组及对照组各39例。对照组单纯接受光动力疗法(PDT)治疗,观察组接受雷珠单抗联合光动力疗法治疗,对比两组视觉功能、敏感度及血清VEGF含量等差异。结果:观察组治疗后a、b波振幅、BCVA值高于对照组,CMT值低于对照组(P<0.05);观察组治疗后12月,100%、25%、10%、5%对比度下的对比度视力均低于对照组(P<0.05);观察组治疗后血清VEGF、PDGF值低于对照组,ES、ES/VEGF、ES/PDGF值高于对照组(P<0.05)。结论:雷珠单抗联合光动力疗法可以优化湿性年龄相关性黄斑变性患者的视觉功能、减少视网膜血管新生,具有积极的临床意义。 Objective:To analyze the effects of Lucentis combined with photodynamic therapy on visual performance and sensitivity as well as serum VEGF levels in patients with wet age-related macular degeneration.Methods:A total of 78 patients (78 eyes)with wet age-related macular degeneration who received treatment in our hospital were included for study and ran-domly divided into observation group and the control group (n =39)according to different treatment methods.Control group received photodynamic therapy (PDT)alone,observation group received Lucentis combined with photodynamic therapy,and then differences in visual performance and sensitivity as well as serum VEGF levels,etc were compared between two groups. Results:a-and b-wave amplitude and BCVA values of observation group after treatment were higher than those of control group,and CMT value was lower than that of control group (P 〈0.05);contrast visual acuity under 100%,25%,10% and 5% contrast of observation group after 12 months of treatment were lower than those of control group (P 〈 0.05 );serum VEGF and PDGF values of observation group after treatment were lower than those of control group,and ES,ES/VEGF and ES/PDGF values were higher than those of control group (P 〈0.05).Conclusion:Lucentis combined with photodynamic thera-py can optimize the visual performance in patients with wet age-related macular degeneration and reduce retinal neovasculariza-tion,and it has positive clinical significance.
作者 何苗 曹奎
出处 《海南医学院学报》 CAS 2016年第17期2066-2068,2072,共4页 Journal of Hainan Medical University
基金 四川省科学技术计划资助项目(2014KD132)~~
关键词 湿性年龄相关性黄斑变性 雷珠单抗 光动力疗法 Wet age-related macular degeneration Lucentis Photodynamic therapy
  • 相关文献

参考文献15

二级参考文献70

  • 1全国眼底病研究协作组.老年性黄斑变性临床诊断标准.眼科新进展,1986,6(4):15-15.
  • 2Nowak J Z. Age-related macular degeneration ( AMD):pathogenesis and therapy [ J]. Pharmacol Rep, 2006, 58(3):353-363.
  • 3Ferrara N. Vascular endothelial growth factor: basic sci-ence and clinical progress [ J ]. EndocrRev,2004,25(4):581-611.
  • 4Lalwani G A, Rosenfeld P J, Fung A E, et al. A varia-ble-dosing regimen with intravitreal rannibizumab fornevovascular age-related macular degeneration : year 2 ofthe PrONTO Study [ J ]. Am J Ophthalmol, 2009, 148(1):43-58.
  • 5Li X X,Hu Y H,Sun X, et al. Bevacizumab for neovas-cular age related macular degeneration in China[ J]. Oph-thalmology, 2012, 119(10) :2087-2093.
  • 6Machalinska A, Karczewicz D. Role of complement sys-tem in the pathogenesis of AMD[ J]. Klin Oczna, 2009,lll(10-12):384-387.
  • 7Potter M J,Szabo S M. One-year outcomes after photo-dynamic therapy in patients with age-related macular de-generation with poor baseline visual acuity [ J ]. GraefesArch Clin Exp Ophthalmol, 2006, 244(8) : 1026-1028.
  • 8The Eye Diseases Prevalence Research Group. Prevalence of agerelated macular degeneration in the United State[J].Archives of Ophthalmology,2004.564-572.
  • 9Bresssler NM,Bressler SB,Fine SL. Age-related maeular degeneration macular degeneration[J].Survey of Ophthalmology,1988.375-413.
  • 10Ferris FL 3rd,Fine SL,Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy[J].Archives of Ophthalmology,1984.1640-1642.

共引文献53

同被引文献136

引证文献15

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部